3165:HK:HK-ChinaAMC MSCI Europe Quality Hedged to USD ETF (HKD)

ETF | Others |

Last Closing

USD 18.52

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.06M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

+0.48 (+2.25%)

USD 161.07B
2800:HK Tracker Fund of Hong Kong

+0.48 (+2.25%)

USD 161.07B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

+2.06 (+2.77%)

USD 20.18B
2828:HK Hang Seng China Enterprises In..

+2.06 (+2.77%)

USD 20.18B
2801:HK iShares Core MSCI China ETF

+0.72 (+3.31%)

USD 17.71B
2801:HK iShares Core MSCI China ETF

+0.72 (+3.31%)

USD 17.71B
2823:HK iShares FTSE A50 China

+0.69 (+4.79%)

USD 14.19B
2823:HK iShares FTSE A50 China

+0.69 (+4.79%)

USD 14.19B

ETFs Containing 3165:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.57% 64% D 67% D+
Dividend Return 0.24% 2% F N/A F
Total Return 10.81% 62% D 65% D
Trailing 12 Months  
Capital Gain 16.11% 72% C 73% C
Dividend Return 1.82% 19% F 15% F
Total Return 17.93% 72% C 72% C
Trailing 5 Years  
Capital Gain 55.11% 80% B- 84% B
Dividend Return 5.95% 41% F 20% F
Total Return 61.06% 80% B- 83% B
Average Annual (5 Year Horizon)  
Capital Gain 9.68% N/A N/A 74% C
Dividend Return 10.81% N/A N/A 72% C
Total Return 1.13% N/A N/A 26% F
Risk Return Profile  
Volatility (Standard Deviation) 12.85% N/A N/A 88% B+
Risk Adjusted Return 84.14% N/A N/A 98% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike